TCT In Brief
This article was originally published in The Gray Sheet
Executive Summary
PREPARE: St. Jude Medical's Proxis embolic protection device helps to resolve ST-segment elevation faster in patients with ST-elevated myocardial infarction, according to results of the 280-patient Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary PCI (PREPARE) trial, presented at the Transcatheter Cardiovascular Therapeutics scientific symposium on Oct. 15 by Karel Koch, University of Amsterdam. ST elevation refers to the electrocardiographic signal associated with impending infarction. In PREPARE, ST-elevation was immediately resolved in 66% of the patients randomized to percutaneous coronary intervention with embolic protection from Proxis, compared to 50% of patients treated with PCI without embolic protection. After 30 minutes, 75% of Proxis patients and 66% of control patients were out of ST-elevation. There were no complications with Proxis, which was 510(k)-cleared in 2003
You may also be interested in...
Hypertension Device Trials, DES Cost Data Headline ACC 2009 In Orlando
Clinical data on minimally invasive treatments for conditions previously treated with drugs or invasive surgery were in the spotlight at the 2009 American College of Cardiology annual scientific sessions
Hypertension Device Trials, DES Cost Data Headline ACC 2009 In Orlando
American College of Cardiology meeting featured “late-breaking trials” of emerging cardiovascular technologies from small companies.
Hypertension Device Trials, DES Cost Data Headline ACC 2009 In Orlando
Clinical data on minimally invasive treatments for conditions previously treated with drugs or invasive surgery were in the spotlight at the 2009 American College of Cardiology annual scientific sessions